These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36353533)

  • 1. Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model.
    Ruiz-Rodado V; Dowdy T; Lita A; Kramp T; Zhang M; Shuboni-Mulligan D; Herold-Mende C; Armstrong TS; Gilbert MR; Camphausen K; Larion M
    Front Oncol; 2022; 12():979537. PubMed ID: 36353533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
    Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort.
    Esteyrie V; Dehais C; Martin E; Carpentier C; Uro-Coste E; Figarella-Branger D; Bronniman C; Pouessel D; Ciron DL; Ducray F; Moyal EC; Network P
    Oncologist; 2021 May; 26(5):e838-e846. PubMed ID: 33524191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas.
    Mörén L; Wibom C; Bergström P; Johansson M; Antti H; Bergenheim AT
    Radiat Oncol; 2016 Apr; 11():51. PubMed ID: 27039175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):896-902. PubMed ID: 29262505
    [No Abstract]   [Full Text] [Related]  

  • 7. First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.
    Taal W; Dubbink HJ; Zonnenberg CB; Zonnenberg BA; Postma TJ; Gijtenbeek JM; Boogerd W; Groenendijk FH; Kros JM; Kouwenhoven MC; van Marion R; van Heuvel I; van der Holt B; Bromberg JE; Sillevis Smitt PA; Dinjens WN; van den Bent MJ;
    Neuro Oncol; 2011 Feb; 13(2):235-41. PubMed ID: 21177338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study.
    Baranovičová E; Galanda T; Galanda M; Hatok J; Kolarovszki B; Richterová R; Račay P
    IUBMB Life; 2019 Dec; 71(12):1994-2002. PubMed ID: 31419008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasively detecting Isocitrate dehydrogenase 1 gene status in astrocytoma by dynamic susceptibility contrast MRI.
    Tan W; Xiong J; Huang W; Wu J; Zhan S; Geng D
    J Magn Reson Imaging; 2017 Feb; 45(2):492-499. PubMed ID: 27367599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
    Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
    J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
    Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
    J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis.
    He XH; Li WT; Gu YJ; Yang BF; Deng HW; Yu YH; Peng WJ
    World J Gastroenterol; 2013 Jul; 19(26):4200-8. PubMed ID: 23864784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of transforming growth factor-beta 1 before and after removal of low- and high-grade astrocytomas.
    Loh JK; Lieu AS; Su YF; Cheng CY; Tsai TH; Lin CL; Lee KS; Hwang SL; Kwan AL; Wang CJ; Hong YR; Chio CC; Howng SL
    Cytokine; 2013 Feb; 61(2):413-8. PubMed ID: 23260996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness.
    Moreira Franco YE; Alves MJ; Uno M; Moretti IF; Trombetta-Lima M; de Siqueira Santos S; Dos Santos AF; Arini GS; Baptista MS; Lerario AM; Oba-Shinjo SM; Marie SKN
    Cancer Metab; 2021 Apr; 9(1):18. PubMed ID: 33910646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy.
    Iwadate Y; Matsutani T; Hirono S; Ikegami S; Shinozaki N; Saeki N
    J Neurooncol; 2015 Sep; 124(3):493-500. PubMed ID: 26243269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
    Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.